Breaking Finance News

Zacks Investment Research announced Check Cap Ltd (NASDAQ:CHEK), boosting its stock price target to $2.00 today

Having a price of $1.88, Check Cap Ltd (NASDAQ:CHEK) traded -0.64% lower on the day. With the last close up -2.30% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.04% over the same period. CHEK has recorded a 50-day average of $1.78 and a two hundred day average of $1.78. Trade Volume was down over the average, with 6,520 shares of CHEK changing hands under the typical 12,857

In a report released on 06/19/2017 Zacks Investment Research bumped up the target of Check Cap Ltd (NASDAQ:CHEK) to $2.00 reporting a potential upside of 0.06%.

Recent Performance Chart

Check Cap Ltd (NASDAQ:CHEK)

Check Cap Ltd has with a one year low of $1.70 and a one year high of $2.95 and has a market capitalization of $0.

A total of 2 analysts have released a report on Check Cap Ltd. zero analysts rating the company a strong buy, zero analysts rating the company a buy, zero analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $8.50.

General Company Details For Check Cap Ltd (NASDAQ:CHEK)

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company's system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient's back, and a personal computer (PC)-based work station for data reconstruction and image processing. The Company's scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. Its scanning capsule employs low-dose X-rays, which allow the system to image the interior lining of the colon even when surrounded by intestinal content. Its capsule transmits information to a receiving device worn on the patient's body that stores the information for off-line analysis.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.